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Cardiac output and urea kinetics in dialysis patients: Evidence sup-
porting the regional blood flow model. The regional blood flow model
predicts that urea sequestration occurs in organs rather than cells, and that
post-dialysis urea rebound is a function of both cardiac index (CI) and
regional blood flow distribution to muscle. We measured cardiac output
(CO) in 100 randomly selected dialysis patients using bioelectric imped-
ance three times during a single dialysis. Mean CO was 5.8 2.1 liter/mm
and Cl averaged 3.1 1.1 liter/min/M2. CI was negatively correlated with
age (r = —0.48,P < 0.01). CI was strongly affected by vasodilator ingestion(yes, N = 36, CI =- 3.5 1.2; no, N = 64, CI = 2.88 0.92, P < 0.006).
CI was not associated with systolic, diastolic, or mean blood pressures, nor
with Hct, although very few severely anemic patients were in the cohort.
Repeat intra-dialytic CO measurements two to three months later in 15
patients with low CI (2.59 0.59 liter/min/M2) and in 13 patients with high
CI (5.00 0.9, P < 0.001) during a urea kinetic modeling session including
30 minutes post-dialysis rebound, sampling showed highly reproducible
values for CO. with a mean absolute value % difference between CO
values measured several months apart of 9.0 17%, r = 0.92. Urea
rebound expressed as the difference (zKt/V10) between equilibrated and
single-pool Kt/V was lower in the high CI group (-—0.099 0.07) than in
the low CI group (—0.16 0.06, P = 0.026), and KT/VI0 as well as
Kt/V30 divided by K/V correlated with CI (r = 0.48 and 0.48, respectively,
P < 0.01). The RBF model was used to compute a group mean predicted
Kt/V30 for the low CI and high CI groups based on measured group
mean values for CI and K/V. The predicted Kt/V30 values for the high Cl
group (--0.097) and the low CI group (—0.183) agreed closely with
measured values. RBF modeled values of CO (7.46 2.96 liter/mm) were
not significantly different from impedance-derived CO (6.93 2.70
liter/mm), and the two CO measures correlated significantly (r = 0.63,P =
0.0003). The results provide support for the regional blood flow model of
urea kinetics.
In the single pooi urea kinetic model [1], urea within the body
is assumed to occupy a single space. the urea concentration of
which is in equilibrium with the urea concentration of the mixed
venous blood. If urea is removed from only a single body pool,
there should be no abrupt increase in the arterial BUN (measured
at the vascular access site) beyond that occurring in the first two
minutes due to dissipation of the A-V gradient [21. There should
be a slight increase in BUN over time due to continued generation
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of urea by the body, but this increase should amount to only about
1 mg/dl per hour. Because a much larger post-dialysis urea
rebound is observed, especially when a highly efficient dialysis
treatment has been given, multicompartment models of urea
kinetics have been proposed [3—6]. The simplest such models
assume that urea is sequestered within cells during dialysis, and
that urea in the extracellular space is in rapid equilibrium with the
blood. In this extracellular/intracellular model, the intracellular
water is thought to be poorly dialyzed with respect to the
extracellular water. As a result, at the end of dialysis, intracellular
urea levels would be higher than those in the extracellular space,
and rebound would occur due to movement of urea from cells to
the extracellular water after dialysis [3—61. An alternative model is
the regional blood flow model, which assumes that urea seques-
tration during dialysis occurs not within cells, but rather within
those organs in which the ratio of blood flow to urea content is
low. This group of organs is made up predominantly of muscle,
and receives only 1 S to 20% of the cardiac outflow, whereas it
contains up to 80% of the total body urea. According to the
regional blood flow model, muscle tissue is poorly dialyzed, such
that at the end of dialysis muscle urea concentration exceeds that
of better perfused organs such as the abdominal viscera. In this
model, post-dialysis urea rebound is a result of urea movement
from muscle to better perfused organs [—1.
The regional blood flow model predicts that post-dialysis urea
rebound will be a function of cardiac index (CI) and the flow
fraction to the low-flow compartment fQl (the low-flow compart-
ment is made up mostly of muscle, and possibly also skin and
bone). Based on analysis of randomly generated input parameters,
we have derived coefficients describing the relation between
post-dialysis urea rebound expressed as Kt/V and the rate of
dialysis K/V, expressed as single-pool Kt/V divided by t. For
example, if fQl 0.15 and CI = 2.85, the equations predict that:
zKt/V =
—0.6 x K/V + 0.03. The slope term of the above
equation (—0.6) is function of CT and fQl [9].
Although the regional blood flow model is grounded in physi-
ology and predicts observed rebound amounts based on reason-
able physiologic values for CI and fQl, a more stringent test of the
model would be to observe post-dialysis urea rebound in patients
in whom CI has been measured, and compare rebound in patients
with low and high values for CI. Accordingly, the purposes of the
present study were to provide such a test.
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Methods
Patient selection
In Phase 1, after informed consent was obtained according to
the principles of the Declaration of Helsinki, CI was measured
three times during dialysis in 100 randomly selected maintenance
hemodialysis patients being dialyzed three times a week at a large
outpatient unit. In Phase 2, CI was remeasured during dialysis in
the 15 patients with the highest CI, and the 15 patients with the
lowest CI. Patients with upper extremity AV accesses only were
studied during Phase 2, to standardize the effect of cardiopulmo-
nary recirculation. Urea modeling was done concurrently with the
CI measurements in Phase 2.
Measurements
Cardiac output was measured by thoracic bioelectric impedance
(NCCOM3-R7; Bomed, Inc., Irvine, CA, USA) [10, 11]. Predi-
alysis serum urea nitrogen (BUN) levels were taken from arterial
needle tubing before injecting heparin. Additional samples were
taken one hour into dialysis: full flow inlet, full flow outlet, and 15
to 20 seconds slow flow inlet. At the end of dialysis, samples were
taken as follows: full flow inlet, 15 to 20 seconds slow flow inlet,
two minutes slow flow inlet, and 30 minutes post-dialysis.
Computations
Anthropometrics. Surface area was estimated from the DuBois
equation [12]. The anthropometric urea distribution volume V
was obtained from the surface area by the Hume-Weyers regres-
sion [13].
Urea kinetic parameters. Single pool Kt/V was computed accord-
ing to the second generation Daugirdas equation using the
anthropometric V instead of W [141:
=
— hi(R 0.008t) + (4 — 3.5R) x 0.55 x UF/V
where R = 15 to 20 seconds BUNpost divided by BUNpre, V =
anthropometric V, t = dialysis session length (hrs), and UF = wt
loss in kg. Equilibrated KtIV was computed using the same
formula, but with R = 30 minutes postBUN/preBUN. Kt/V was
then calculated as equilibrated Kt/V — single-pool Kt/V. Access
recirculation was measured in all patients near the end of dialysis
using ultrasound dilution as described by Krivitski [15] and was
zero in all but one patient (in the low CI group) whose data were
excluded from the analysis.
Regional blood flow equations
As in Daugirdas and Schneditz [9], random input values were
used to generate terms for the general equation:
Kt/V = - m X K/V + b
The group mean cardiac index for the low CI group or for the
high CI group was put into the equation with random assignment
of the remaining parameters to solve for the optimum coefficients
"m" and "h". In this manner, two different sets of coefficients were
established for each group. These were then used to solve for the
expected group mean iKt/V for the low and high CI groups,
respectively. The equations used and the parameters were those
listed in the Appendix of Daugirdas and Schneditz [9]. There are
three typographical errors in that appendix: (1) In the formula for
auch, line 2, there should he no parenthesis prior to lal-q; (2) the
parenthesis prior to a21 in the formula for a22 should be deleted;
and (3) in the formula for doseh, g should be gn. Otherwise, the
only parameters changed were the use of a constant 0.85 for the
fQh term, and use of either 2.6 or 5.0 for the CI term. The
coefficients "ni" and "b" were obtained by regressing Kt/V3() (the
difference between the equilibrated Kt/V and that at the imme-
diate end of dialysis) on K/V (computed by dividing the immedi-
ate post-dialysis Kt/V by the hours of dialysis.
Modeling of cardiac output for individual patients using the
regional blood flow model
Two model parameters, cardiac output (CO) and urea distri-
bution volume (V) were identified by fitting experimental data to
the regional blood flow model [7—9]. Pre-dialysis, end-dialysis and
30-minute post-dialysis BUN values, ultrafiltration rates, blood-
side urea clearances (K), treatment times (t), extracorporeal
blood flows (Qb), and urea generation rates (G, estimated from
BUNpost and BUNpre and corrected for 93% plasma water
content) were used as model inputs, while CO, V, equilibrated
KtV (KtVeq), and SDS (SD) between residuals of experimental and
fitted data were obtained as model outputs.
Data fitting was done using the Solver option offered by MS
Excel version 5.0, minimizing SD with constraints for cardiac
output (CO: 0.5 x 2.4 x body surface area < CO < 1.5 X 4.2 X
body surface area), V (0.5 X TBWathrOPOmetriC <V < 1.5 X
TBWanthrop(,mtrc), BUNend (—0.01 < (BUNend, exp-BUNend,
model)/BUNpre < 0.01), and 30 minutes BUNpost (—0.02 <
(BUNpost3O, exp-BUNpost3O, model)/BUNpre < 0.02). Model
parameters such as access flow (Qac = 0.8 liter/mm), fractional
volume of the high flow compartment (fVh = 0.2), fractional
perfusion of the high flow compartment (fQh = 0.85), and
capillary permeability surface area product (PS = 20 liter/mm)
were assumed at constant values as reported previously. Access
recirculation (Ra = 0) and residual clearance (Kr = 0) were
assumed to be negligible.
Effective clearances (ClhSh, Cl10) were calculated from analyt-
ical expressions of areas under modeled concentration curves
(AUC) and modeled amounts of BUN removed from both high
(doseh) and low flow compartments (dose!). Equilibrated KtV
(KtVeq) was calculated as the sum of high and low flow compart-
ment clearances, experimental treatment times, and modeled
end-dialytic BUN-distribution volumes as described previously
[7—9].
Results
Impedance cardiac output in Phase 1 (100 dialysis patients)
Mean CO was 5.8 2.1 liter/mm, and mean CI was 3.1 1.1
liter/min/M2. Systolic, diastolic, and mean blood pressures aver-
aged 139, 79, and 99 mm Hg. Mean body surface area (SA) was
1.86 0.25 M2, Anthropometric V was 39.5 7.8 L. Mean Hct
was 32% 5.2. Half of the patients were taking anti-hypertensive
medications and 36% were on vasodilators (minoxidil, hydral-
azinc). Cardiac index was negatively correlated with age (Fig. 1,
r = —0.48, P < 0.01). CI was strongly affected by vasodilator
ingestion (yes, N = 36, CI = 3.5 1.2; no, N = 64, CI 2.88
0.92, P < 0.006). Frequency distribution plots of CI in patients
taking and not taking vasodilators are shown in Figure 2. CI
measurements were highly reproducible over time. The coefficient
of variation of intradialytic Cl measurements repeated within
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Fig. 1. Relation between measured intradialytic CI and patient age. The
patients are grouped into those taking vasodilators (0) and those not
taking such medications (•). The negative correlation coefficient is highly
significant, and the negative relation between age and CI has been
observed by others (r =
—0.48).
several hours was quite small (5.2 3.9%). A sex effect (63 males,
37 females) was present for CO but not for CI. Twenty-five
percent of the patients were obese by body mass index (BMI); CI
(but not CO) was reduced in obese patients, suggesting perhaps
deviation from an/thropometric assumptions in obese patients. CI
was not associated with systolic, diastolic, or mean blood pres-
sures, nor with Hct. Of the 100 patients, 15 had a venovenous
access, 80 had a lower arm graft or fistula, and 5 had an upper arm
or thigh graft. CI did not differ significantly among these three
groups (2.8 0.79, 3.1 1.1, and 3.7 1.0 liter/min/M2,
respectively).
Impedance cardiac output and urea kinetic modeling result
(Phase 2)
In addition to the patient with access recirculation, data from
one additional patient with low CI were excluded due to several
missing samples. There remained data on 15 patients in the high
CI group and on 13 patients in the low CI group. The main
modeling parameters are listed in Table 1 for the high and low CI
groups. In the repeat measurement of CI in these 30 patients with
the lowcst and highest CI values, which were taken two to three
months later, the mean absolute value % difference between
intradialytic CO values at repeat evaluation versus CO values at
initial screening was 9.0 17%, r = 0.92. Thus, the separation in
CI between the two groups remained high, with almost a 100%
mean difference between them (Table 1). There was no difference
in weight, sex ratio, or treatment parameters between the two
groups, although the high CI group tended to have more women
and weigh less. The measured dialyzer clearance, modeled single
pool volume, and rate of dialysis (KJV) were all quite similar in
the two groups. Despite this, there was a marked difference in
Kt/V between the two groups, averaging —0.16 Kt/V units in the
low CI group and —0.099 in the high CI group. The mean iKt/V
values were quite similar to those predicted (—0.183 and —0.097,
respectively) on the basis of the regional blood flow model
Fig. 2. A. Frequency distribution plots of Ci in patients not taking vasodi-
lators. The mean value is 2.88 liter/min/M2; so = 0.92; N = 64. B.
Frequency distribution plots of CI in patients taking vasodilators. The
mean value is 3.51 liter/min/M2, significantly higher than in patients not on
this type of medication. The SD is 1.26; N = 36.
calculations (Fig. 3). When Kt/V was plotted against CI, a highly
significant correlation (r = 0.48, P < 0.01) was found (Fig. 4).
The two-minute post-dialysis samples also were used to exam-
ine rebound. The Kt/V23() (defined as equilibrated Kt/V —Kt/V
computed using the Daugirdas second generation formula and the
post-samples obtained after 2 mm of slow flow) averaged —0.12
0.062 in the low CI group, and —0.074 0.069 in the high CI
group (P < 0.05). The zKt/V23() value correlated with the
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Low
cardiac
index
High
cardiac
index P
Number of patients 13 15
Impedance CI liter/miniM2 2.6 0.59 5.0 0.93 <0.001
Impedance CO liter/mm 4.6 1.15 8.9 1.9 <0.001
RBF modeled CO liter/mm 5.9 2.7 8.8 2.5 <0.001
Weight kg 75.4 12.6 66.3 11.5 NS
Sex (M:F) 6:7 4:11 NS
Session length hours 3.7 0.38 3.5 0.42 NS
Dialyzer blood water Kd 180 24 185 27 NS
mi/mm
Qb mI/mm 342 19 346 13 NS
Predialysis BUN mg/dl 49 9.2 48 18 NS
Postdialysis BUN mg/dl 29 5.6 29 II NS
PDUR % of post-sample 5.7 2.3 3.7 2.6 <0.05
Kt/Vsp 1.14 0.15 1.10 0.21 NS
KtIVeq 0.98 0.13 1.00 0.21 NS
K/V 0.31 0.05 0.32 0.07 NS
Kt/V30-measured —0.16 0.06 —0.099 0.07 <0.026
Predicted group K/V slope —0.69 —0.32
("m")
Predicted group intercept 0.03 0.005
("b")
1Kt/V30-rbf. predicted for —0.183 —0.097 NA
the group
Modeled single-pool V 35.7 8.0 36.2 8.3 NS
(V)
Anthropometric V (Va) 37.6 4.0 35.4 3.7 NS
Vratio (V,/Va) 0.96 0.24 1.01 0.15 NS
0.28
0.26
0.24
0.22
0.20
. 0.18
0.16
C' 0.14
0.12
0.10
0.08
0.06
0.04
0.02
0.00
impedance derived CI value (r = 0.46, P < 0.05). Because it is
known that the A/V urea gradient will be increased in patients
with low CI [2], these results suggest that CI values affect urea
rebound even after the A/V urea gradient closes, and point to an
effect of Cl on the true "compartment" phase of the urea
rebound.
Discussion
Our results demonstrate that intradialytic cardiac index (CI) in
dialysis patients not taking vasodilators tends to be rather low,
about 2.9 liter/min/M2. This is similar to results found by authors
of the present paper using either thoracic electric bioimpedance
[16—18] or thermodilution [191. In the 100 patients that were
screened, an inverse relationship between cardiac output and age
was demonstrated. Patients taking hydralazine or minoxidil
tended to have higher CI values than those not taking anti-
hypertensive medications or who were taking other anti-hyperten-
sive medications. The type of vascular access did not affect the CI,
although few patients (N = 5) with upper arm or thigh grafts were
included in the analysis. There was a non-significant trend for CI
to be higher in patients with lower arm AV accesses (mean CI =
3.13) than with venovenous accesses (mean CI = 2.79).
Our data suggest that the thoracic electric bioimpedance (TEB)
method of measuring cardiac output [10, 111 in dialysis patients
Table 1. Modeling results (mean SD)
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Fig. 4. Regression plot of .Kt/1/ against CI in patients preselected for high(N = 15) and low (N = 13) CI. The regression is highly significant (P <
0.01). Symbols arc: (•) patients initially drawn from the low CI group; (0)
patients from the high CI group; r = 0.48.
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Fig. 5. Regression plot of regional blood flow modeled cardiac output versus
impedance measured cardiac output. The regression coefficient (r = 0.63) is
highly significant (P < 0.001). Symbols are: (•) low CO group; (0) high
CO group.
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Fig. 3. Bar graph showing the (/1 in the low and high CI groups as well as the
mean obsereed and RBF-predicted Kt/V values in each group. The Kt/V
values are significantly different and the means are similar to the predicted
group means based on the RBF model.
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has a low coefficient of variation on repeat assessment. The low
coefficient of variation of 5% within a single dialysis and 9%
across means of two intradialytic CI measurements taken three
months apart is quite impressive. This is now the fourth published
study in which we used TEB to measure CO in dialysis patients.
Initially, we found that TEB-CO measurements identified the well
known increase in CI during acetate-based dialysate use [16]. In a
second study, we found that food ingestion during dialysis was
associated with an accelerated fall in MAP but a tendency toward
a rise in CI [17], consistent with published results of others [20].
We also found that lowering dialysate temperature increased
blood pressure by maintaining or increasing peripheral vascular
resistance [18]. In abstract form, we recently have examined the
ability of TEB-CO to predict dialysis-induced hypotension, and
found that TEB-CO fell in all but one patient to similar levels
during such episodes [21]. Taken together, this experience sug-
gests that TEB-CO is a useful tool to measure CI in dialysis
patients. The hemodynamic relevance of TEB-CO measurements
is further enhanced by the relations between TEB-CI and urea
rebound identified in the present study.
The regional blood flow model of urea kinetics predicts that
whenever muscle blood flow and cardiac output are low, post-
dialysis rebound will be large. Conversely, when muscle blood flow
and cardiac index are high, rebound should be small. The exact
solution to the RBF model is now available [8] and allows for
quantitative predictions of the relationship between CI and
postdialysis urea rebound. We have used this model and the
knowledge from observations by us and others that mean CI is
often about 2.85, mean access blood flow about 800 mI/mm, and
the physiological inference that perfusion to the low flow organs is
about 15% of cardiac output, to define a formula to predict the
post-dialysis rebound in the majority of patients [9], a formula that
has been found to be useful by others as well [221. The present
results suggest that, in the absence of vasodilator ingestion, mean
intradialytic CI is indeed about 2.9, and further support the
appropriateness of the rate equation [9] to predict Kt/V. The
present results also demonstrate that, if we preselect patients for
low or high CI, then the post-dialysis rebound will differ in
direction and magnitude as predicted by the RBF model. Further-
more, cardiac output as predicted by the regional blood flow
model, making an assumption that 15% of cardiac output goes to
the low flow fraction, and that access recirculation is about 800
mI/mm, is not significantly different from that measured by
impedance. These results further support both the regional blood
flow model and the usefulness of thoracic bioelectric impedance
in dialysis patients.
In summary, thoracic electric bioimpedance measurement of
cardiac output (CO) in dialysis patients is highly reproducible.
Cardiac output correlates negatively with age. Cardiac index
averaged 2.9 in patients not taking vasodilators, close to the mean
value of 2.85 used in deriving a prediction equation of post-
dialysis urea rebound based on the regional blood flow model [9].
Cardiac output was significantly higher in patients receiving
vasodilators (hydralazine, minoxidil). Post-dialysis urea rebound
correlated with intradialytic CI and was different in patients with
high cardiac index versus patients with low cardiac index. The
relation between cardiac index and post-dialysis urea rebound was
as predicted by the regional blood flow model.
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